Associated Papers
Optical coherence tomography-derived biomarkers for disease severity in choroideremia and choroideremia carriers.
Choi HS et al.
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie, 2025
CHM mutation spectrum and disease: An update at the time of human therapeutic trials.
Zeitz C et al.
Human Mutation, 2021
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
Han RC et al.
Expert Opinion on Orphan Drugs, 2021
CHM/REP1 Transcript Expression and Loss of Visual Function in Patients Affected by Choroideremia.
Di Iorio V et al.
Investigative Ophthalmology & Visual Science, 2019
Crystals and Fatty Acid Abnormalities Are Not Present in Circulating Cells From Choroideremia Patients.
Radziwon A et al.
Investigative Ophthalmology & Visual Science, 2018
Select a paper to view details